Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product

Biochemical and Biophysical Research Communications

Volumn 267, Issue 1, 2000, Pages 368-372

  Zumpe, Emma T ^a   Tilakaratne, Nanda ^a   Fraser, Neil J ^b   Christopoulos, George ^a   Foord, Steven M ^b   Sexton, Patrick M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; IODINE 125; MEMBRANE PROTEIN; PEPTIDE; RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN; CHIMERA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANIMALIA;

EID: 0034614398     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1943     Document Type: Article

References (16)

1. Sexton P. M., Findlay D. M., Martin T. J. Curr. Med. Chem. 6:1999;1067-1093.
2. Wimalawansa S. J. Crit. Rev. Neurobiol. 11:1997;167-239.
3. Muff R., Born W., Fischer J. A. Eur. J. Endocrinol. 133:1995;17-20.
4. Sexton P. M. Curr. Opin. Drug Discov. Dev. 2:1999;440-448.
5. Foord S. M., Marshall F. H. Trends Pharmacol. Sci. 20:1999;184-187.
6. Fluhmann B., Muff R., Hunziker W., Fischer J. A., Born W. Biochem. Biophys. Res. Commun. 206:1995;341-347.
7. Njuki F., Nicholl C. G., Howard A., Mak J. C., Barnes P. J., Girgis S. I., Legon S. Clin. Sci. (Colch.). 85:1993;385-388.
8. McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., and Foord, S. M.Nature393, 333-339.
9. Fraser N. J., Wise A., Brown J., McLatchie L. M., Main M. J., Foord S. M. Mol. Pharmacol. 55:1999;1054-1059.
10. Bhulmann N., Leuthauser K., Muff R., Fischer J. A., Born W. Endocrinology. 140:1999;2883-2890.
11. Christopoulos G., Perry K. J., Morfis M., Tilakaratne N., Gao Y., Fraser N. J., Main M. J., Foord S. M., Sexton P. M. Mol. Pharmacol. 56:1999;235-242.
12. Muff. R., Buhlmann N., Fischer J. A., Born W. Endocrinology. 140:1999;2924-2927.
13. Bhogal R., Smith D. M., Bloom S. R. Endocrinology. 130:1992;906-913.
14. Kuestner R. E., Elrod R. D., Grant F. J., Hagen F. S., Kuijper J. L., Matthewes S. L., O'Hara P. J., Sheppard P. O., Stroop S. D., Thompson D. L., Whitmore T., Findlay D. M., Houssami S., Sexton P. M., Moore E. E. Mol. Pharmacol. 46:1994;246-255.
15. Moore E. E., Kuestner R. E., Stroop S. D., Grant F. J., Matthewes S. L., Brady C. L., Sexton P. M., Findlay D. M. Mol. Endocrinol. 9:1995;959-968.
16. Gorn A. H., Lin H. Y., Yamin M., Auron P. E., Flannery M. R., Tapp D. R., Manning C. A., Lodish H. F., Krane S. M., Goldring S. R. J. Clin. Invest. 90:1992;1726-1735.